Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Wei Wang and Jianfeng Zhou.
Wei Wang
Connection Strength
0.732
Jianfeng Zhou
  1. Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality. Signal Transduct Target Ther. 2020 12 14; 5(1):292.
    View in: PubMed
    Score: 0.230
  2. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol. 2020 09; 17(9):992-994.
    View in: PubMed
    Score: 0.223
  3. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020 Jul; 146(1):137-146.e3.
    View in: PubMed
    Score: 0.221
  4. Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms. Eur J Hum Genet. 2021 08; 29(8):1312-1315.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.